|
Variables
|
Controls (n = 10)
|
IHD (n = 15)
|
DCM (n = 19)
|
|---|
|
Males (n, %)
|
7 (70)
|
10 (67)
|
9 (60)
|
|
Age (years)
|
34 ± 11
|
59 ± 14*
|
52 ± 18*
|
|
Heart rate (bpm)
|
62 ± 8
|
64 ± 11
|
62 ± 9
|
|
BP systolic (mmHg)
|
119 ± 9
|
136 ± 13
|
129 ± 21
|
|
BP diastolic (mmHg
|
69 ± 8
|
82 ± 9
|
79 ± 8
|
|
BMI kg/m2
|
27 ± 9
|
29 ± 11
|
28 ± 9
|
|
LV-EDV (index), ml/m2
|
79 ± 16
|
78 ± 14
|
101 ± 11*§
|
|
LV-ESV (index) ml/m2
|
34 ± 7
|
47 ± 12*
|
56 ± 14*§
|
|
LV-EF (%)
|
57 ± 2
|
40 ± 10*
|
43 ± 7*
|
|
LV mass (index), g/m2
|
54 ± 11
|
46 ± 10
|
78 ± 9*
|
|
LGE (n, %)
|
/
|
15(100)
|
7 (47)
|
|
GLS (Medis)
|
20.12 ± 2.2
|
18.3 ± 2.2*
|
15.9 ± 2.4*§
|
|
GLS (CVI42)
|
23.51 ± 2.8
|
20.3 ± 3.9
|
16.8 ± 2.2
|
- IHD Ischaemic heart disease, DCM Dilated cardiomyopathy, BMI Body mass index, LV-EDV Left ventricular end-diastolic volume, LV-ESV End-systolic volume, GLS Global longitudinal strain, one-way ANOVA, Bonferroni post-hoc tests for the differences from control group, * - for the differences from controls, § between the groups; p < 0.05 is considered significant
